SCHEMBL24178920

SCHEMBL24178920

CNc1cc(Nc2ncc(Cl)c(Nc3ccc(C)cc3P(C)(C)=O)n2)c(OC)cc1N1CCC(N2CCN(C)CC2)CC1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ INSR P06213 13/20 0.74
▸ IGF1R P08069 13/20 0.74
▸ ALK Q9UM73 13/20 0.74
▸ EGFR P00533 8/20 0.68
▸ CHEK1 O14757 1/20 0.68
▸ AURKA O14965 1/20 0.68
▸ NUAK1 O60285 1/20 0.68
▸ JAK2 O60674 1/20 0.68
▸ STK10 O94804 1/20 0.68
▸ PRKD3 O94806 1/20 0.68
▸ SLC34A2 O95436 1/20 0.68
▸ CHEK2 O96017 1/20 0.68
▸ ABL1 P00519 1/20 0.68
▸ CD74 P04233 1/20 0.68
▸ ERBB2 P04626 1/20 0.68
▸ LCK P06239 1/20 0.68
▸ FYN P06241 1/20 0.68
▸ FES P07332 1/20 0.68
▸ CSF1R P07333 1/20 0.68
▸ YES1 P07947 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24179044 0.93 ALK (0.85) INSRIGF1RALKEGFRCHEK1
SCHEMBL24179062 0.92 INSR (0.74) INSRIGF1RALKEGFRCHEK1
SCHEMBL24178974 0.90 ALK (0.68) INSRIGF1RALKEGFRCHEK1
SCHEMBL11916431 0.89 ALK (0.85) INSRIGF1RALKEGFRCHEK1
SCHEMBL24178978 0.89 INSR (0.71) INSRIGF1RALKEGFRCHEK1
SCHEMBL24179085 0.88 ALK (0.68) INSRIGF1RALKEGFRCHEK1
SCHEMBL24178921 0.87 INSR (0.60) INSRIGF1RALKEGFRCHEK1
SCHEMBL24179124 0.86 ALK (0.74) INSRIGF1RALKEGFRCHEK1
SCHEMBL31498856 0.86 ALK (0.86) INSRIGF1RALKEGFRCHEK1
SCHEMBL24179415 0.86 ALK (0.74) INSRIGF1RALKEGFRCHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230322822-A1 ARYL PHOSPHOROUS OXIDE COMPOUNDS AND USE THEREOF CHENGDU DI'AO JIUHONG PHARMACEUTICAL FACTORY (CN) 2023-10-12 — — US disclosed
US-20230322822-A1 ARYL PHOSPHOROUS OXIDE COMPOUNDS AND USE THEREOF CHENGDU DI'AO JIUHONG PHARMACEUTICAL FACTORY (CN) 2023-10-12 — — US disclosed
EP-4177258-A1 ARYLPHOSPHINE OXIDE COMPOUNDS AND USE THEREOF Chengdu Di'Ao Jiuhong Pharmaceutical Factory (CN) 2023-05-10 — — EP disclosed
WO-2022002241-A1 ARYLPHOSPHINE OXIDE COMPOUNDS AND USE THEREOF 成都地奥九泓制药厂 2022-01-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230322822-A1 ARYL PHOSPHOROUS OXIDE COMPOUNDS AND USE THEREOF ALK, EGFR, ROS1 INSR 550/4885IGF1R 108/4885ALK 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback